PR
PRVA.US Privia Health Group Inc
- Market cap
- USD 3.23B
- P/E
- 97.2x
- P/B
- 3.85x
- ROE
- 4.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is PRVA.US undervalued?
Graham numberThe Graham number of Privia Health Group Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Privia Health Group Inc fundamental analysis
No fundamental analysis for Privia Health Group Inc yet.
Privia Health Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Privia Health Group Inc
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and a…
Full company profilePrivia Health Group Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Privia Health Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 658M | 786M | 817M | 966M | 1.36B | 1.66B | 1.74B | 2.12B | 2.52B |
| Gross Profit | 56.5M | 68.5M | 82.6M | 63.7M | 135M | 162M | 177M | 209M | 276M |
| Operating Income | 2.16M | 16.1M | 25.4M | -217M | -19.1M | 20.6M | 17.0M | 34.2M | 53.0M |
| EBITDA | 3.23M | 17.5M | 27.2M | -215M | -14.0M | 35.6M | 35.1M | 53.8M | 78.0M |
| Net Income | -3.04M | 8.24M | 31.2M | -188M | -8.59M | 23.1M | 14.4M | 22.9M | 34.1M |
| EPS | -0.03 | 0.08 | 0.30 | -1.75 | -0.08 | 0.19 | 0.11 | 0.18 | 0.26 |
| Balance Sheet | |||||||||
| Total Assets | 249M | 270M | 329M | 686M | 793M | 1,000M | 1.14B | 1.37B | 1.56B |
| Total Liabilities | 163M | 163M | 185M | 236M | 274M | 393M | 452M | 578M | 691M |
| Shareholders' Equity | 88.5M | 110M | 147M | 427M | 499M | 561M | 635M | 737M | 816M |
| Cash & Short-term Investments | 39.1M | 46.9M | 84.6M | 321M | 348M | 390M | 491M | 480M | 446M |
| Total Debt | 67.0M | 43.1M | 33.7M | 46.5M | 11.5M | 8.29M | 5.59M | 9.53M | 8.26M |
| Cash Flow | |||||||||
| Operating Cash Flow | 5.25M | 24.4M | 38.9M | 55.1M | 47.2M | 80.8M | 109M | 163M | -25.9M |
| Capital Expenditure | 220K | 5.71M | 380K | 547K | 104K | 113K | 5.02M | 1.20M | 78.7K |
| Free Cash Flow | 5.03M | 18.6M | 38.5M | 54.5M | 47.1M | 80.7M | 104M | 162M | -26.0M |
| Ratios | |||||||||
| ROE | -3.4% | 7.5% | 21.3% | -44.1% | -1.7% | 4.1% | 2.3% | 3.1% | 4.2% |
| ROA | -1.2% | 3.1% | 9.5% | -27.4% | -1.1% | 2.3% | 1.3% | 1.7% | 2.2% |
| Net Profit Margin | -0.5% | 1.0% | 3.8% | -19.5% | -0.6% | 1.4% | 0.8% | 1.1% | 1.4% |
| Debt to Equity | 0.76x | 0.39x | 0.23x | 0.11x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Privia Health Group Inc dividends
Privia Health Group Inc has not paid dividends in the last 8 fiscal years.
Who owns Privia Health Group Inc
- Insiders 6.19%
- Institutions 93.81%
- Public & others 0.00%
- Shares outstanding 128M
- Free float 109M
Top funds holding PRVA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7.69M | 6.02% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.90M | 3.05% | +8.13% | Sep 2026 |
| iShares Russell 2000 ETF | 3.06M | 2.39% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 2.73M | 2.14% | +4.90% | Sep 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 1.52M | 1.19% | +1.79% | Sep 2026 |
| Touchstone Small Company A | 1.35M | 1.06% | +71.53% | Sep 2026 |
| Fidelity Small Cap Index | 1.32M | 1.04% | +0.13% | Aug 2026 |
| Fidelity Small Cap Growth | 1.28M | 1.00% | 0.00% | Aug 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 1.17M | 0.92% | -0.05% | Oct 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 1.15M | 0.90% | -0.29% | Oct 2026 |
| Fidelity Select Health Care Svcs Port | 1.14M | 0.90% | +0.24% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 1.14M | 0.89% | -0.38% | Oct 2026 |
| Fidelity Select Health Care | 1.08M | 0.85% | -41.91% | Aug 2026 |
| BlackRock Advantage Small Cap Core Instl | 1.06M | 0.83% | +5.13% | Sep 2026 |
| Fidelity Enhanced Small Cap Core ETF | 851K | 0.67% | +0.27% | Oct 2026 |
| Fidelity Stock Selector Small Cap | 768K | 0.60% | +6.05% | Aug 2026 |
| Eventide Healthcare & Life Sciences I | 738K | 0.58% | 0.00% | Jun 2026 |
| Franklin Small Cap Growth Adv | 728K | 0.57% | -22.15% | Sep 2026 |
| State Street® SPDR® S&P 600™ Sm Cp GrETF | 724K | 0.57% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 703K | 0.55% | +1.14% | Sep 2026 |
Top institutions holding PRVA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 21.4M | 16.75% | +12.30% | Jun 2026 |
| FMR Inc | 12.8M | 10.06% | -1.51% | Jun 2026 |
| Durable Capital Partners LP | 11.6M | 9.11% | -3.74% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 6.57M | 5.14% | +4.63% | Jun 2026 |
| Rubicon Founders LLC | 5.97M | 4.67% | +0.38% | Jun 2026 |
| Vanguard Capital Management, LLC | 5.16M | 4.04% | +2.95% | Jun 2026 |
| State Street Corp | 4.91M | 3.84% | +9.26% | Jun 2026 |
| Van Berkom and Associates Inc | 3.69M | 2.88% | -0.71% | Sep 2026 |
| Geode Capital Management, LLC | 3.13M | 2.45% | +8.11% | Jun 2026 |
| Riverbridge Partners LLC | 2.90M | 2.27% | -3.45% | Sep 2026 |
| Bank of New York Mellon Corp | 2.89M | 2.26% | -1.73% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 2.63M | 2.06% | +2.93% | Sep 2026 |
| Principal Financial Group Inc | 2.47M | 1.94% | -4.45% | Sep 2026 |
| Wellington Management Company LLP | 2.13M | 1.67% | +850.59% | Jun 2026 |
| UBS Asset Mgmt Americas Inc | 1.95M | 1.52% | -5.05% | Jun 2026 |
| Fort Washington Investment Advisors Inc | 1.74M | 1.36% | +65.15% | Sep 2026 |
| BlackBarn Capital Partners LP | 1.59M | 1.24% | 0.00% | Jun 2026 |
| Nuveen, LLC | 1.47M | 1.15% | +54.53% | Jun 2026 |
| Bank of America Corp | 1.43M | 1.12% | +14.01% | Jun 2026 |
| Charles Schwab Investment Management Inc | 1.37M | 1.08% | +4.22% | Jun 2026 |
Privia Health Group Inc company profile
- Company name
- Privia Health Group Inc
- Ticker
- PRVA.US
- Exchange
- USA Stocks
- Listed since
- Apr 28, 2021
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 1,226
- Fiscal year end
- December
- Address
- 950 North Glebe Road, Arlington, VA, United States, 22203
- Phone
- 571 366 8850
- Website
- priviahealth.com
About Privia Health Group Inc
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. Further, it offers clinical services, data analytics and day-to-day operational support through preventive health and data-driven coordination, it helps practices elevate the quality of patient care and increase patient engagement. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Privia Health Group Inc management
10- Mr. Parth MehrotraCEO & Director · born 1979
- Mr. David Mountcastle CPA, MBAExecutive VP & CFO · born 1970
- Mr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate Secretary · born 1965
- Mr. Sarath DegalaChief Operating Officer
- Mr. Konda MullapudiExecutive VP & CTO
- Mr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate Communications
- Ms. Dana Fields CPAChief Audit & Compliance Officer
- Ms. Jenny HardingChief People Officer
- Mr. Jay StevensSenior VP & Chief Growth Officer
- Mr. Eric J. BeyerExecutive Vice President of Medical Groups